Skip to content
Home/GPs/Lazard Elaia Capital
Lazard Elaia Capital

Lazard Elaia Capital

Joint venture launched in April 2024 between Lazard (US investment bank, 75 percent) and Elaia Partners (French VC founded 2002, 25 percent); deploys EUR 420M across Lazard Elaia Capital Fund I (vintage 2025 EUR 300M Growth Series C+ to buyout) + Elaia Digital Venture Fund V (vintage 2024 EUR 120M early-to-mid stage VC) + the Elaia Legacy Portfolio of pre-JV Elaia investments (Criteo IPO 2013, Mirakl 2012 unicorn, Shift Technology 2014 active).

AUM
€420M
Funds
4
vintages 2002–2026
Portfolio
14
Exits
3
SectorsSoftwareHealthcareBusiness Services

Key facts

HQParis, France
Founded2024

Recent exits

Gleamer
Healthcare · 2026 · 7yr hold
Cosmian
Cybersecurity · 2025 · 6yr hold
Criteo
TMT · 2013 · 6yr hold

Coverage notes

4 funds tracked, 17 portfolio companies (14 active · 3 realized). Verified weekly from public filings and deal announcements.

Funds & portfolio

Every fund Lazard Elaia Capital has raised, with its portfolio companies. Hand-checked from public filings.

4 funds
Elaia DeepTech Seed Fund III (DTS3)VC
2026 · 0yr€134M0 active

No portfolio companies tracked yet.

Lazard Elaia Capital Fund IGrowth
2025 · 1yr€300M1 active

Unrealized

1 held
HealthcareFrance· Entry 2021
Elaia Digital Venture Fund VVC
2024 · 2yr€120M1 active

Unrealized

1 held
DexoryActive
TMTUnited Kingdom· Entry 2023
Elaia Legacy FundVC
2002 · 24yr€200M12 active · 3 realized

Unrealized

12 held
TMTFrance· Entry 2020
AQEMIAActive
HealthcareFrance· Entry 2020
AviwellActive
HealthcareFrance· Entry 2024
DJUSTActive
TMTFrance· Entry 2021
HealthcareFrance· Entry 2026
HumminkActive
IndustrialsFrance· Entry 2023
LinkupActive
TMTFrance· Entry 2024
MimicActive
IndustrialsSwitzerland· Entry 2024
MiraklActive
TMTFrance· Entry 2012
NcodiNActive
IndustrialsFrance· Entry 2024
PrimaaActive
HealthcareFrance· Entry 2019
TMTFrance· Entry 2014

Realized

3 exits
CosmianExited 2025
CybersecurityFrance· Entry 2019
Trade Saleto
CriteoExited 2013
TMTFrance· Entry 2007
IPOto
GleamerExited 2026
HealthcareFrance· Entry 2019
Trade Saleto
Track Lazard Elaia Capital

Saved GPs appear in your watchlist, one click from your workspace.

About Lazard Elaia Capital

Lazard Elaia Capital is a joint venture launched in April 2024 between Lazard (US investment bank, 75 percent) and Elaia Partners (French VC founded 2002, 25 percent), with €420 million of assets under management as of December 2024. The partnership deploys across Lazard Elaia Capital Fund I (vintage 2025, €300M Growth Series C+ to buyout) plus complementary Elaia vintage funds, combining institutional Lazard banking heritage with Elaia's European technology venture expertise.

Investment thesis

Lazard Elaia Capital targets European technology companies at growth equity and selective buyout stages, with equity tickets typically ranging from €20 million to €80 million per transaction. The platform combines Lazard's institutional investment banking network with Elaia's multi-decade European tech VC pattern recognition, enabling growth-stage commitments in profitable scaling European tech companies that have outgrown traditional VC funding rounds.

Recent activity

The platform tracks 3 funds, 14 active portfolio companies and 1 realised exit across the inaugural deployment of the Lazard Elaia partnership. As a recently launched platform (April 2024 JV), the firm is in the active deployment phase with realised exits expected to materialise progressively. Detailed buyer names and multiple data available on Pro at €29/month.

Last updated June 2026 · Sourced from public filings